Adoption of AI scribes across GPs
The research, published in npj Digital Medicine, surveyed 598 practising GPs across the UK and found that 40% were currently using AI scribes, while a further 23% had used them previously. Among those currently using the technology, AI scribes were used in an average of 60% of consultations.
AI scribes use ambient voice technology to listen to consultations and automatically generate clinical notes, referral letters and other documentation. GPs reported that the technology helps:
- Reduce administrative burden
- Improve workflow
- Save time spent writing notes
Concerns about AI scribes
However, the study also revealed widespread concerns around:
- Patient safety and inaccuracy
- Uncertainty about who is responsible if something goes wrong
- Where patient conversations are stored and protected
- The AI scribe’s difficulties with accents and people who speak English as a foreign language
The researchers found that adoption varied significantly according to GP and practice characteristics rather than local population factors. Men, GP trainers, clinicians working more sessions each week and those undertaking private practice were more likely to use AI scribes.
"AI scribes are becoming increasingly common in UK primary care, largely through informal adoption rather than coordinated implementation. While many GPs report benefits in reducing administrative workload and improving documentation, concerns around safety, liability and governance remain. As use continues to grow, clear national guidance and robust evaluation will be essential to ensure these technologies support safe, effective and equitable patient care."Lead author Dr Christina Derksen, from Queen Mary's Wolfson Institute of Population Health
The study suggests that AI scribes are already becoming embedded in day-to-day general practice, despite recent caution from NHS England and professional bodies regarding the use of products that do not meet regulatory and safety requirements.
The future of AI scribes
The researchers argue that national standards are urgently needed to address issues including liability, data security, training and clinical governance, and to ensure that benefits are realised consistently across the NHS.
This study was supported by both Barts Charity and Cancer Research UK.
"Artificial intelligence has enormous potential to help tackle some of the pressures facing healthcare. That’s why we’ve invested so much money into digital health innovations at Barts Health NHS Trust. At the same time, it’s vital that innovation is done in a way that prioritises patient safety. We’re proud to support research that helps ensure new technologies are implemented safely, effectively and in ways that benefit patients and healthcare professionals alike."Fiona Miller Smith, Chief Executive of Barts Charity
